rxstat › Shortages › Lorazepam

Lorazepam shortage status

Partial shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Some Lorazepam products are in shortage in Canada (1 of 27 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is May 1, 2026.
Products affected
1 / 27
In shortage since
Apr 21, 2026
Est. full return
May 1, 2026
Reports on file
116
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
APO-LORAZEPAM
0.5MG · TABLET · APOTEX INC
DIN 00655740 · since Apr 21, 2026, est. end May 1, 2026 · Disruption of the manufacture of the drug.
Resolved
LORAZEPAM INJECTION USP
4MG · SOLUTION LIQUID · SANDOZ CANADA INCORPORATED
DIN 02243278 · ended Jun 22, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LORAZEPAM
2MG · TABLET · TEVA CANADA LIMITED
DIN 00637750 · ended Mar 25, 2026 · Disruption of the manufacture of the drug.
Discontinued
ATIVAN
1MG · TABLET · PFIZER CANADA ULC
DIN 02041464
Discontinued
ATIVAN
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02041456
Resolved
TEVA-LORAZEPAM
2MG · TABLET · TEVA CANADA LIMITED
DIN 00637750 · ended Feb 25, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-LORAZEPAM
1MG · TABLET · TEVA CANADA LIMITED
DIN 00637742 · ended Feb 4, 2026 · Disruption of the manufacture of the drug.
Discontinued
ATIVAN
2MG · TABLET · PFIZER CANADA ULC
DIN 02041448
Discontinued
ATIVAN
1MG · TABLET · PFIZER CANADA ULC
DIN 02041421
Discontinued
ATIVAN
0.5MG · TABLET · PFIZER CANADA ULC
DIN 02041413
Discontinued
ATIVAN
2MG · TABLET · PFIZER CANADA ULC
DIN 02041472
Resolved
ATIVAN
2MG · TABLET · PFIZER CANADA ULC
DIN 02041472 · ended Oct 17, 2025 · Disruption of the manufacture of the drug.

Showing 12 of 60 reports. All reports are on file with Health Canada.

What's happening

Lorazepam is currently affected by an active shortage report filed with Health Canada by APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Lorazepam is classified under “ANXIOLYTICS” (ATC N05BA).

Recent changes

Common questions

When will Lorazepam be back in stock in Canada?

The latest manufacturer estimate is May 1, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Lorazepam in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (anxiolytics)

Widespread shortageBuspirone5 of 8 reported products affected · est. return Aug 3, 2026Widespread shortageChlordiazepoxide2 of 3 reported products affectedWidespread shortageOxazepam6 of 10 reported products affectedPartial shortageAlprazolam4 of 20 reported products affected · est. return Jul 3, 2026Partial shortageDiazepam4 of 18 reported products affectedPartial shortageHydroxyzine2 of 8 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.